Metoprolol Succinate NDC 72516-032

Product information

Brand name (proprietary)

Metoprolol Succinate

Generic name (nonproprietary)

metoprolol succinate

Active ingredients

Metoprolol tartrate — 100 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Oryza Pharmaceuticals, Inc

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207206

Marketing start

Apr 27, 2022

Listing expires

Dec 31, 2026

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 72516-032_2b4bd7b3-d6df-e98e-e063-6394a90a7f9dSPL ID 2b4bd7b3-d6df-e98e-e063-6394a90a7f9dSPL set ID 6cfe96df-bd75-432d-b2c2-e26143ca36ddRxCUI 866412, 866419, 866427, 866436UNII W5S57Y3A5LUPC 0372516030018, 0372516033019, 0372516031015

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472516003201 followed by a unit qualifier and the quantity Copy

Package 72516-0032-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207206

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.